Who Owns Whom

ASPEN PHARMACARE HOLDINGS LTD

Company Organogram

R 750.00(ZAR) estimated $ 44.50 (USD)*

Buy Now Add to Cart
Enquire about this organogram

ASPEN PHARMACARE HOLDINGS LTD Organogram

Aspen Pharmacare Holdings Ltd operates through its subsidiaries, and manufactures, markets, imports, and distributes branded and generic pharmaceutical products, consumer healthcare, as well as treatments for acute and chronic conditions, covering both hospital and consumer markets through its key business segments. The group has 24 facilities consisting of 17 Finished dose form facilities and 7 Active pharmaceutical ingredient facilities.

Aspen presently supplies medicines to 115 countries and regions. During the 2025 financial year, the group supplied medicines to more than 60 low- and middle-income countries, including 50 of the 108 countries identified in the Access to Medicines Index as countries where better access to medicines is most needed.

Business segments include:
• Commercial Pharmaceuticals:
- Injectables - Sterile products in injectable form primarily administered in hospitals and also those prescribed and administered either by physicians or in a retail pharmacy environment. Principal therapeutic areas covered are anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines.
- Over the counter - Products that do not require prescription and are primarily sold in the retail pharmacy and fast-moving consumer goods sectors, where brand recognition, marketing and communication with pharmacists are influential in consumers’ product choices.
- Prescription - All other products which generally require a prescription from a healthcare professional. Primary therapeutic areas are anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids.
• Manufacturing:
- Active pharmaceutical ingredients (API) - all API sales excluding heparin-based APIs
- Finished dose form (FDF) - FDF products manufactured for third parties
- Heparin - Heparin-based API sales to third parties

Production facilities:
5 - South Africa (Johannesburg; East London; Cape Town; Gqeberha)
2 - Mexico (leased)
3 - The Netherlands
1 - France
2 - Australia
1 - New Zealand
1 - Kenya
1 - Tanzania
2 - Brazil
1 - Germany
1 - Ireland
1 - USA
1 - Ghana
1 - India